Search -

Displaying 81 - 100 of 1339

Sort: Relevancy | Date

News Daily News

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

Todd Neale

February 25, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

News Daily News

Having Twins Ups the Risk of CVD Over the Next Year

Caitlin E. Cox

February 06, 2025

News Daily News

Taxing Sugar-Sweetened Drinks Modestly Impacts BMI

L.A. McKeown

February 05, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

Shelley Wood

January 31, 2025

News Daily News

AHA Stats Show CV Health of Americans Remains Dire

Michael O'Riordan

January 28, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

L.A. McKeown

January 10, 2025

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Daily News

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Yael L. Maxwell

November 14, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Advertisement

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Having Twins Ups the Risk of CVD Over the Next Year

Taxing Sugar-Sweetened Drinks Modestly Impacts BMI

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

TCTMD’s Top 10 Most Popular Stories for January 2025

AHA Stats Show CV Health of Americans Remains Dire

January 2025 Dispatch for the CV Team

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

December 2024 Dispatch for the CV Team

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

November 2024 Dispatch for the CV Team

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content